PTGS2 and rheumatoid arthritis: In a rheumatoid arthritis rat model, DHM significantly reduces inflammation by activating the Nrf2 pathway, which lowers levels of IL-1β, IL-6, TNF-α, and cyclooxygenase-2 (COX-2) (Chu et al., 2018).